Cortactin knockdown results in decreased FA turnover. by Alok Tomar (139282)

Extent of demyelination is decreased following NgR knock down. by Fereshteh Pourabdolhossein (624998)

Knockdown of NG2 by siRNA results in decreased viability and a reduction in PARP levels. by Frank Maus (792209)

Decrease in activity of transcriptional factor NRF2 in MCF-7 cells exposed to gDNA^OX at final concentrations of 50 ng/mL for 2 hours. by Svetlana V. Kostyuk (473354)

IC₅₀s data of antimalarials against controls. by Winnie Okore (14139712)

Subjects:

Suppression of the growth defects in flippase mutants by decreased synthesis of PI. by Kanako Yamagami (703555)

Drugs IC₅₀s data during the study period. by Winnie Okore (14139712)

Subjects:

WT∶MU ratio is decreased in differentiated hOE-MSCs. by Nathalie Boone (234904)

Inhibition of Hsp90 abolished VEGF-mediated eNOS phosphorylation and decreased NO production and cell viability in BAECs. by Yuanzhuo Chen (802891)

CCR2 depletion decreases lipid accumulation in the liver and WAT. by Seung Joo Lee (1766020)

“…Increased lipid droplets and fat size in HFD WT were decreased in HFD KO. Arrow indicates a crown-like structure. …”

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

SNPs IC₅₀s data at codon 876 during the study period. by Winnie Okore (14139712)

Subjects:

WT1 mRNA and protein levels are decreased by GnRH. by Debalina Bagchi (686046)

The expression of 5-hmC was decreased in ESCC tissues and cell lines. by Xuejiao Shi (1684186)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Inhibition of GATA2 in clinical primary AML cells decreased the survival rate during chemo treatment. by Li Yang (6520)

Detection of the Challenging mutations at 1% VAF and 50 ng DNA input. by Lizhi Yu (12476136)

The decrease in blood flow disrupts CV pruning. by Lin Wen (557398)

Knockout or inhibition of CCR1 decreases peritoneal inflammation and CAIA. by Nuruddeen D. Lewis (192385)

GluN2A(D731N) decreases channel open probability. by Kai Gao (120150)

“…The di-heteromeric mutant (2A-D731N) and tri-heteromeric receptors with two-copies of the mutant subunit (D731N/D731N) showed a prolonged inhibition rate, reflecting a decreased channel open probability. …”